163 related articles for article (PubMed ID: 27228236)
1. Bacterial Lipopolysaccharide, Lipopolysaccharide-Binding Protein, and Other Inflammatory Markers in Obesity and After Bariatric Surgery.
Tuomi K; Logomarsino JV
Metab Syndr Relat Disord; 2016 Aug; 14(6):279-88. PubMed ID: 27228236
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery.
Clemente-Postigo M; Roca-Rodriguez Mdel M; Camargo A; Ocaña-Wilhelmi L; Cardona F; Tinahones FJ
Surg Obes Relat Dis; 2015; 11(4):933-9. PubMed ID: 25737102
[TBL] [Abstract][Full Text] [Related]
3. Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.
du Plessis J; Korf H; van Pelt J; Windmolders P; Vander Elst I; Verrijken A; Hubens G; Van Gaal L; Cassiman D; Nevens F; Francque S; van der Merwe S
PLoS One; 2016; 11(12):e0166048. PubMed ID: 27992443
[TBL] [Abstract][Full Text] [Related]
4. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial.
Pei R; DiMarco DM; Putt KK; Martin DA; Gu Q; Chitchumroonchokchai C; White HM; Scarlett CO; Bruno RS; Bolling BW
Br J Nutr; 2017 Dec; 118(12):1043-1051. PubMed ID: 29179781
[TBL] [Abstract][Full Text] [Related]
5. Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice.
Laugerette F; Furet JP; Debard C; Daira P; Loizon E; Géloën A; Soulage CO; Simonet C; Lefils-Lacourtablaise J; Bernoud-Hubac N; Bodennec J; Peretti N; Vidal H; Michalski MC
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E374-86. PubMed ID: 22094473
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
7. Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity.
Jialal I; Rajamani U; Adams-Huet B; Kaur H
Atherosclerosis; 2014 Sep; 236(1):182-7. PubMed ID: 25063948
[TBL] [Abstract][Full Text] [Related]
8. Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome.
Jialal I; Devaraj S; Bettaieb A; Haj F; Adams-Huet B
Atherosclerosis; 2015 Jul; 241(1):130-7. PubMed ID: 25978344
[TBL] [Abstract][Full Text] [Related]
9. Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.
Yang PJ; Lee WJ; Tseng PH; Lee PH; Lin MT; Yang WS
Surg Obes Relat Dis; 2014; 10(6):1182-7. PubMed ID: 24713521
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation and inflammation: is lipopolysaccharide binding protein the link?
Fang H; Liu A; Dirsch O; Dahmen U
Cytokine; 2013 Oct; 64(1):71-8. PubMed ID: 23958732
[TBL] [Abstract][Full Text] [Related]
11. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.
Hersoug LG; Møller P; Loft S
Nutr Res Rev; 2018 Dec; 31(2):153-163. PubMed ID: 29362018
[TBL] [Abstract][Full Text] [Related]
12. Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.
Lim PS; Chang YK; Wu TK
Blood Purif; 2019; 47(1-3):28-36. PubMed ID: 30219816
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipopolysaccharide on inflammation and insulin action in human muscle.
Liang H; Hussey SE; Sanchez-Avila A; Tantiwong P; Musi N
PLoS One; 2013; 8(5):e63983. PubMed ID: 23704966
[TBL] [Abstract][Full Text] [Related]
14. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.
Gonzalez-Quintela A; Alonso M; Campos J; Vizcaino L; Loidi L; Gude F
PLoS One; 2013; 8(1):e54600. PubMed ID: 23349936
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population.
Awoyemi A; Trøseid M; Arnesen H; Solheim S; Seljeflot I
Atherosclerosis; 2019 Jul; 286():53-59. PubMed ID: 31100620
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery.
Trøseid M; Nestvold TK; Rudi K; Thoresen H; Nielsen EW; Lappegård KT
Diabetes Care; 2013 Nov; 36(11):3627-32. PubMed ID: 23835694
[TBL] [Abstract][Full Text] [Related]
17. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial.
Vors C; Pineau G; Drai J; Meugnier E; Pesenti S; Laville M; Laugerette F; Malpuech-Brugère C; Vidal H; Michalski MC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3427-35. PubMed ID: 26151336
[TBL] [Abstract][Full Text] [Related]
18. The association between plasma endotoxin, endotoxin pathway proteins and outcome after ischemic stroke.
Klimiec E; Pasinska P; Kowalska K; Pera J; Slowik A; Dziedzic T
Atherosclerosis; 2018 Feb; 269():138-143. PubMed ID: 29353229
[TBL] [Abstract][Full Text] [Related]
19. Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14.
Laugerette F; Alligier M; Bastard JP; Drai J; Chanséaume E; Lambert-Porcheron S; Laville M; Morio B; Vidal H; Michalski MC
Mol Nutr Food Res; 2014 Jul; 58(7):1513-8. PubMed ID: 24687809
[TBL] [Abstract][Full Text] [Related]
20. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
Dhillon AK; Kummen M; Trøseid M; Åkra S; Liaskou E; Moum B; Vesterhus M; Karlsen TH; Seljeflot I; Hov JR
Liver Int; 2019 Feb; 39(2):371-381. PubMed ID: 30269440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
